US Patent Issued to ACCURE THERAPEUTICS on April 7 for "Treatment regimen for the treatment of neurological diseases or conditions" (California Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,259, issued on April 7, was assigned to ACCURE THERAPEUTICS S.L. (Barcelona, Spain).

"Treatment regimen for the treatment of neurological diseases or conditions" was invented by Pablo Villoslada Diaz (Los Altos, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "It relates to a compound of formula (I), or a pharmaceutically or veterinary acceptable salt thereof, or any stereoisomer or mixtures of stereoisomers, either of the compound of formula (I) or of any of its pharmaceutically or veterinary acceptable salts, wherein R1, R2, and R3 are as defined herein, for use in the treatment or prevention of a neurological disease or condition which resul...